A randomized phase III study of docetaxel alone versus docetaxel plus S‐1 in patients with previously treated non‐small cell lung cancer: JMTO LC09‐01

BACKGROUND: This study evaluated the efficacy and safety of the combination chemotherapy of docetaxel plus S‐1 in patients with previously treated non‐small cell lung cancer (NSCLC) compared to docetaxel alone. METHODS: Patients with previously treated NSCLC were randomly assigned to docetaxel alone...

Descripción completa

Detalles Bibliográficos
Autores principales: Atagi, Shinji, Daimon, Takashi, Okishio, Kyoichi, Komuta, Kiyoshi, Okano, Yoshio, Minato, Koichi, Kim, Young Hak, Usui, Ryo, Tabata, Chiharu, Tamura, Atsuhisa, Kawahara, Masaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569902/
https://www.ncbi.nlm.nih.gov/pubmed/37609677
http://dx.doi.org/10.1111/1759-7714.15080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569902/
https://www.ncbi.nlm.nih.gov/pubmed/37609677
http://dx.doi.org/10.1111/1759-7714.15080

Ejemplares similares